LIQUID BIOPSY
Clinical trials for LIQUID BIOPSY explained in plain language.
Never miss a new study
Get alerted when new LIQUID BIOPSY trials appear
Sign up with your email to follow new studies for LIQUID BIOPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Urine DNA test may let some bladder cancer patients stop immunotherapy early
Disease control Recruiting nowThis study tests whether a urine DNA test can help guide when to stop immunotherapy in people with a very high-risk type of bladder cancer that cannot be fully removed by surgery. About 53 participants will receive immunotherapy and then be monitored with urine tests and scans. I…
Matched conditions: LIQUID BIOPSY
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Urine test may spare bladder cancer patients from unnecessary second surgery
Diagnosis Recruiting nowThis study looks at whether a simple urine test for tumor DNA can tell which bladder cancer patients truly need a second surgery after their first tumor removal. About 196 adults with non-muscle-invasive bladder cancer will be randomly assigned to have their repeat surgery decisi…
Matched conditions: LIQUID BIOPSY
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Pee test could replace painful bladder scopes for cancer patients
Diagnosis Recruiting nowThis study is testing whether a simple urine test that looks for cancer DNA can help decide when patients with high-risk bladder cancer need a cystoscopy (a camera exam of the bladder). Cystoscopy is effective but uncomfortable and can cause infections. The goal is to safely redu…
Matched conditions: LIQUID BIOPSY
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Simple blood test could spare prostate cancer patients from unnecessary scans
Diagnosis Recruiting nowThis study aims to develop a blood test that detects RNA from tiny particles (exosomes) to predict if prostate cancer has spread to the bones. Researchers will analyze blood samples from 1,000 men with newly diagnosed prostate cancer and compare results with PSMA PET scans. The g…
Matched conditions: LIQUID BIOPSY
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Urine test may spare bladder cancer patients from unnecessary second surgery
Diagnosis Recruiting nowThis study looks at whether a simple urine test can detect leftover cancer after initial surgery for high-risk bladder cancer. The goal is to help doctors decide who truly needs a second surgery, avoiding unnecessary procedures and their risks. About 60 adults with high-risk non-…
Matched conditions: LIQUID BIOPSY
Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Simple blood and urine test could spot bladder cancer return
Diagnosis Recruiting nowThis study is testing a new liquid biopsy that uses blood and urine samples to help diagnose, monitor treatment, and predict recurrence in people with urothelial carcinoma (a type of bladder cancer). Researchers will enroll 300 participants and compare the liquid biopsy results w…
Matched conditions: LIQUID BIOPSY
Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Can a simple blood test tell who needs more cancer treatment?
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for cancer DNA (called a liquid biopsy) can find leftover cancer cells after surgery in people with stage III colorectal cancer. The goal is to see if this test can help doctors decide who needs additional treatment and who ca…
Matched conditions: LIQUID BIOPSY
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple blood test tell if cancer is really gone?
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for cancer DNA (called ctDNA) can find leftover cancer cells after surgery in people with colorectal cancer that has spread to the liver. The goal is to see which test works best at predicting if the cancer will come back. Thi…
Matched conditions: LIQUID BIOPSY
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC